metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Interacción hormonal endoexocrina pancreática: modelo in vivo sin filtro hepá...
Información de la revista
Vol. 69. Núm. 5.
Páginas 436-444 (mayo 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 69. Núm. 5.
Páginas 436-444 (mayo 2001)
Acceso a texto completo
Interacción hormonal endoexocrina pancreática: modelo in vivo sin filtro hepático en la rata
Hormonal interaction between the endocrine and the exocrine pancreas: in vivo model without hepatic filter in the rat
Visitas
9250
R.L. Ferrer1, J. Medrano, R. Calpena, M. Diego, M. Moltó, M.L. Graells, M.T. Pérez, P. Cansado, I. Oliver, F. Pérez, A. Arroyo
Departamento de Patología y Cirugía. Facultad de Medicina. Universidad Miguel Hernández. Elche. Alicante
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen
Introducción

Dada la controversia aún existente, se ha desarrollado un modelo experimental para determinar en el páncreas el papel de la insulina y el glucagón sobre su función exocrina, y el papel de la colecistocinina y la secretina sobre su función endocrina.

Material y métodos

El modelo se ha aplicado a un total de 60 ratas anestesiadas y estimuladas con dosis fisiológicas y suprafisiológicas de dichas hormonas administradas mediante perfusión continua. Se han medido en el jugo pancreático el volumen y las actividades y producciones enzimáticas de amilasa, lipasa y tripsina a los 0, 20, 40 y 60 min del inicio de las perfusiones. En el plasma se han determinado los valores de insulina, glucagón y glucosa a los 0, 10, 30 y 60 min.

Resultados

A dosis tanto fisiológicas como suprafisiológicas, la insulina y el glucagón modifican la secreción pancreática exocrina, y la colecistocinina altera la secreción pancreática endocrina. La secretina incrementa la secreción endocrina sólo a dosis suprafisiológicas.

Conclusiones

En condiciones basales in vivo y con dosis de estimulación hormonal de rango fisiológico, existe una interacción hormonal endoexocrina en la glándula pancreática.

Palabras clave:
Insulina
Glucagón
Colecistocinina
Secretina
Interacción endoexocrina pancreática
Introduction

In view of the continuing controversy regarding the interaction between the endocrine and the exocrine pancreas, we developed an experimental model to determine the role of insulin and glucagon on exocrine function, as well as to determine the role of cholecystokinin and secretin on endocrine function.

Material and methods

We applied the model to 60 anesthetized rats, stimulated with continuous infusion of physiological and supraphysiological doses of the above-mentioned hormones. The volume and activity of amylase, lipase and trypsin in pancreatic juice were measured at 0, 20, 40 and 60 minutes after starting the infusion. Plasma levels of insulin, glucagon and glucose levels were measured at 0, 10, 30 and 60 minutes.

Results

Insulin and glucagon modify exocrine secretion of the pancreas at physiological and supraphysiological doses. Cholecystokinin alters endocrine secretion of the pancreas at both physiological and supraphysiological doses, whereas secretin increases endocrine secretion only at supraphysiological doses.

Conclusion

Hormonal interaction between the endocrine and the exocrine pancreas was found in vivo under basal conditions with hormonal stimulation using physiological doses.

Key words:
Insulin
Glucagon
Cholecystokinin
Secretin
Endoexocrine interaction
Pancreas
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.V. Schonfeld, M.K. Muller.
The insulo-acinar axis of the pancreas.
Med Klin, 88 (1993), pp. 724-728
[2.]
T. Murakami, T. Fujita, T. Miyake, A. Ohtsuka, T. Taguchi, A. Kikuta.
The insulo-acinar portal and insulo-venous drainage systems in the pancreas of the mouse, dog, monkey and certain other animals: a scanning electron microscopic study of corosion casts.
Arch Histol Cytol, 56 (1993), pp. 127-147
[3.]
M. Bendayan, S. Gregoire.
Immunohisto- and cytochemical studies of pancreatic enzymes in peri-insular and tele-insular acinar cells of strptozotocin-induced diabetic rats.
Pancreas, 2 (1987), pp. 272-282
[4.]
A.A. Harper, H.S. Raper.
Pancreozymin, a stimulant of secretion of pancreatic enzymes, in extracts of the small intestine.
J Physiol, 102 (1943), pp. 115-125
[5.]
R. Calpena, J. Medrano, J.M. Pardo, M.T. Pérez, M.A. Carbonell, F. Candela, et al.
Interacción entre la secretina y CCK en la estimulación de la función exocrina pancreática en el perro.
Cir Esp, 42 (1987), pp. 830-838
[6.]
S.J. Konturek.
Pancreatic dose-response curves to intravenous secretin in man.
Gastroenterology, 58 (1970), pp. 828-832
[7.]
J.M. Polak, I. Coulling, S.R. Bloom, A.G. Pearse.
Immunofluorescent localization of secretin and enteroglucagon in human intestinal mucosa.
Scand J Gastroenterol, 6 (1971), pp. 739-744
[8.]
M.P. Dubois, C. Paulin, J.A. Chayvialle.
Identification of gastrin-secreting cells and cholecystokinin-secreting cells in the gastrointestinal tract of the humans fetus and adult man.
Cell Tissue Res, 175 (1976), pp. 351-356
[9.]
R.H. Unger, A.M. Eisentraut.
Entero-insular axis.
Arch Intern Med, 123 (1969), pp. 261-266
[10.]
F. Pérez, A. Puigdollers, E. Castell, M. Armengol, B. Oller, J.C. Otero, et al.
Estudio celular endocrino en duodeno y páncreas tras la práctica de una gastrectomía parcial en la rata.
Cir Esp, 63 (1998), pp. 87-92
[11.]
D.G. Fernig, R.J. Mayer.
Insulin processing in primary endosomes is not responsible for insulin resistance observed in parametrial adipocytes from lactating rats.
Biochim Biophys Acta, 1010 (1989), pp. 237-245
[12.]
C.R. Kahn, Y. Shechter.
Insulina, agentes hipoglucemiantes orales y farmacología del páncreas endocrino.
Las bases farmacológicas de la terapéutica, pp. 1415-1445
[13.]
S. Rojdmarck, G. Bloom, M.C.Y. Chou, J.B. Field.
Hepatic extraction of exogenous insulin and glucagon in the dog.
Endocrinology, 102 (1978), pp. 806-813
[14.]
M. Otsuki, C. Sakamoto, M. Maeda, H. Yuu, S. Morita, S. Baba.
Effect of caerulein on exocrine and endocrine pancreas in the rat.
Endocrinology, 105 (1979), pp. 1396-1399
[15.]
J. Szecówka, P.E. Lins, S. Efendic.
Effects of cholecystokinin, gastric inhibitory polypeptide and secretin on insulin and glucagon secretion in rats.
Endocrinology, 110 (1982), pp. 1268-1272
[16.]
H. Harada, F. Kochi, E. Hanafusa, T. Kobayashi, H. Oka, I. Kimura.
Studies on the effect of glucagon on human pancreatic secretion by analysis of endoscopically obtained pure pancreatic juice.
Gastroenterol Jpn, 20 (1985), pp. 28-36
[17.]
G. Cucchiaro, G.D. Branum, M. Farouk, G. Mansour, C.M. Kuhn, D.C. Anthony, et al.
The effects of liver denervation on the regulation of hepatic biliary secretion.
Transplantation, 54 (1992), pp. 129-136
[18.]
H. Hasegawa, Y. Okabayashi, M. Koide, Y. Kido, T. Okutani, K. Matsushita, et al.
Effect of islet hormones on secretin-stimulated exocrine secretion in isolated perfused rat pancreas.
Dig Dis Sci, 38 (1993), pp. 1278-1283
[19.]
U.R. Folsch, K.G. Wormsley.
Pancreatic enzyme response to secretin and cholecystokinin pancreozymin in the rat.
J Physiol, 324 (1973), pp. 79-94
[20.]
J.D. Elashoff.
Analysis of repeated measures designs.
BMDP Technical Report, (1986), pp. 83
[21.]
A. Sofranková.
Effect of exogenous and endogenous insulin on the secretory response of the pancreas to the octapeptide of cholecystokinin (CCK-8) in normal rats.
Physiol Bohemoslov, 33 (1984), pp. 391-398
[22.]
T. Berg, L. Johansen, I.B. Brekke.
Insulin potentiates cholecystokinin (CCK)-induced secretion of pancreatic kallikrein.
Acta Physiol Scand, 123 (1985), pp. 89-95
[23.]
R.D. Duan, C. Wicker, C. Erlanson-Albertsson.
Effect of insulin administration on contents, secretion and synthesis of pancreatic lipase and colipase in rats.
Pancreas, 6 (1991), pp. 595-602
[24.]
H. Ohara.
Clinical and experimental studies on the entero-insular and insulo-acinar correlations.
Endocrine gut and pancreas, pp. 321-333
[25.]
S.G. Pierzynowsky, P. Podgurniak, M. Mikolajczyk, W. Szczesny.
Insulin and the parasympathetic dependence of pancreatic juice secretion in healthy and alloxan diabetic sheep.
Q J Exp Physiol, 71 (1986), pp. 401-407
[26.]
C. Álvarez, M.A. López.
Effect of alloxan diabetes on exocrine pancreatic secretion in the anesthetized rabbit.
Int J Pancreatol, 5 (1989), pp. 229-238
[27.]
T.M. Biedzinski, D. Bataille, M.A. Devaux, H. Sarles.
The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat.
Peptides, 8 (1987), pp. 967-972
[28.]
G. Adler.
Effect of glucagon on the secretory process in the rat exocrine pancreas.
Cell Tissue Res, 182 (1977), pp. 193-204
[29.]
L. Jarret.
Effect of glucagon on the acinar portion of the pancreas.
Endocrinology, 70 (1962), pp. 867-871
[30.]
M. Papp, S. Feher, B. Varga, G. Folly.
Humoral influences on local blood flow and external secretion of the resting dog pancreas.
Acta Med Acad Sci Hung, 34 (1977), pp. 185-198
[31.]
A. Wettergren, B. Schjoldager, P.E. Mortensen, J. Myhre, J. Christiansen, J.J. Holst.
Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
Dig Dis Sci, 38 (1993), pp. 665-673
[32.]
A. Balkan, A.B. Stefens, J.H. Strubbe, J.E. Bruggink.
Biphasic insulin secretion after intravenous but not after intraportal CCK-8 infusion in rats.
Diabetes, 39 (1990), pp. 702-706
[33.]
H. Mineo, N. Iwaki, T. Onaga, S. Kato.
Effects of intravenous infusions of cholecystokinin-8 and pentagastrin on plasma concentrations of insulin and glucagon in sheep.
Res Vet Sci, 56 (1994), pp. 298-302
[34.]
H. Mineo, N. Iwaki, K. Kogishi, R. Zabielski, T. Onaga, S. Kato.
Effects of intravenous infusions of cholecystokinin (CCK) -8 on exocrine and endocrine pancreatic secretion in conscious sheep.
Comp Biochem Physiol, 111 (1995), pp. 133-138
[35.]
B. Ahren, M. Pettersson, K. Uvnas-Moberg, M. Gutniak, S. Efendic.
Effects of cholecystokinin (CCK)-8, CCK-33 and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
Diabetes Res Clin Pract, 13 (1991), pp. 153-162
[36.]
M. Otsuki, S. Nakano, I. Tachibana.
Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatic rats.
Regul Pept, 52 (1994), pp. 85-95
[37.]
S. Karlsson, B. Ahren.
Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Acta Physiol Scand, 135 (1989), pp. 271-278
[38.]
E.J. Verspohl, C. Zoll, M.A. Wahl, H.P.T. Ammon.
The role of cholecystokinin (CCK8) on glucose production and elimination, and on plasma insulin and glucose in rats.
Peptides, 13 (1992), pp. 1091-1095
[39.]
B. Ahren, I. Lundquist.
Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse.
Diabetologia, 20 (1981), pp. 54-59
[40.]
B. Glaser, B. Shapiro, J. Glowniak, S.S. Fajans, A.I. Vinik.
Effect of secretin on the normal and pathological B-cell.
J Clin Endocrinol Metab, 66 (1988), pp. 1138-1143
[41.]
M. Imamura, Y. Hattori, O Nishida, T. Honda, Y. Shimada, T. Miyahara, et al.
Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma.
Pancreas, 5 (1990), pp. 467-473
[42.]
B. Ahren, I. Lundquist.
Secretin potentiates cholinergically induced glucagon secretion in the mouse.
Acta Physiol Scand, 128 (1986), pp. 575-578
Copyright © 2001. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos